Cargando…

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway

Fungal infections are becoming more prevalent and problematic due to the continual rise of immune deficient patients as well as the progressive development of drug resistance towards currently available antifungal drugs. There has been a significant increase in the development of antifungal compound...

Descripción completa

Detalles Bibliográficos
Autores principales:	McEvoy, Kyle, Normile, Tyler G., Del Poeta, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559796/ https://www.ncbi.nlm.nih.gov/pubmed/32825250 http://dx.doi.org/10.3390/jof6030142

Ejemplares similares

Steryl Glycosides in Fungal Pathogenesis: An Understudied Immunomodulatory Adjuvant
por: Normile, Tyler G., et al.
Publicado: (2020)

Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids
por: Lazzarini, Cristina, et al.
Publicado: (2018)

Sphingolipids as Regulators of the Phagocytic Response to Fungal Infections
por: Bryan, Arielle M., et al.
Publicado: (2015)

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
por: Mor, Visesato, et al.
Publicado: (2015)

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1
por: Normile, Tyler G., et al.
Publicado: (2022)

Erratum for Mor et al., “Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids”
por: Mor, Visesato, et al.
Publicado: (2018)

Special Issue: Novel Antifungal Drug Discovery
por: Del Poeta, Maurizio
Publicado: (2016)

Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4(+) or CD8(+) T Cells for Complete Host Protection
por: Normile, Tyler G., et al.
Publicado: (2021)

Animal Models of Cryptococcus neoformans in Identifying Immune Parameters Associated With Primary Infection and Reactivation of Latent Infection
por: Normile, Tyler G., et al.
Publicado: (2020)

Vaccine protection by Cryptococcus neoformans Δsgl1 is mediated by γδ T cells via TLR2 signaling
por: Normile, Tyler G., et al.
Publicado: (2022)

Biological Roles Played by Sphingolipids in Dimorphic and Filamentous Fungi
por: Fernandes, Caroline Mota, et al.
Publicado: (2018)

New insights on the development of fungal vaccines: from immunity to recent challenges
por: Medici, Natasha P, et al.
Publicado: (2015)

The biological functions of sphingolipids in plant pathogenic fungi
por: Zhu, Xue-Ming, et al.
Publicado: (2023)

Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine
por: dos Reis, Thaila Fernanda, et al.
Publicado: (2021)

Everybody needs sphingolipids, right! Mining for new drug targets in protozoan sphingolipid biosynthesis
por: MINA, JOHN G. M., et al.
Publicado: (2018)

A Highlight on the Inhibition of Fungal Carbonic Anhydrases as Drug Targets for the Antifungal Armamentarium
por: Supuran, Claudiu T., et al.
Publicado: (2021)

Sphingolipids and Inositol Phosphates Regulate the Tau Protein Phosphorylation Status in Humanized Yeast
por: Randez-Gil, Francisca, et al.
Publicado: (2020)

Mass Spectrometry-Based Proteomics of Fungal Pathogenesis, Host–Fungal Interactions, and Antifungal Development
por: Ball, Brianna, et al.
Publicado: (2019)

Microdomain Protein Nce102 Is a Local Sensor of Plasma Membrane Sphingolipid Balance
por: Zahumenský, Jakub, et al.
Publicado: (2022)

Antineoplastic Agents Targeting Sphingolipid Pathways
por: Kroll, Alexander, et al.
Publicado: (2020)

Targeting the Sphingolipid Rheostat in Gliomas
por: Zaibaq, Faris, et al.
Publicado: (2022)

Sphingolipidomics: An Important Mechanistic Tool for Studying Fungal Pathogens
por: Singh, Ashutosh, et al.
Publicado: (2016)

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
por: Tscherner, Michael, et al.
Publicado: (2011)

Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal
por: Rhome, Ryan, et al.
Publicado: (2011)

Exploiting Fungal Virulence-Regulating Transcription Factors As Novel Antifungal Drug Targets
por: Bahn, Yong-Sun
Publicado: (2015)

Membrane Sphingolipids Regulate the Fitness and Antifungal Protein Susceptibility of Neurospora crassa
por: Huber, Anna, et al.
Publicado: (2019)

Abnormalities of Sphingolipids Metabolic Pathways in the Pathogenesis of Psoriasis
por: Burger, Beatriz, et al.
Publicado: (2023)

An Invertebrate Host to Study Fungal Infections, Mycotoxins and Antifungal Drugs: Tenebrio molitor
por: Canteri de Souza, Patrícia, et al.
Publicado: (2018)

Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2014)

Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
por: Young, Simon A., et al.
Publicado: (2012)

Membrane engineering of S. cerevisiae targeting sphingolipid metabolism
por: Lindahl, Lina, et al.
Publicado: (2017)

Sphingolipid-Transporting Proteins as Cancer Therapeutic Targets
por: Samaha, Doaa, et al.
Publicado: (2019)

The Sphingolipid Biosynthetic Pathway Is a Potential Target for Chemotherapy against Chagas Disease
por: Koeller, Carolina Macedo, et al.
Publicado: (2011)

Susceptibility Testing of Fungi to Antifungal Drugs
por: Sanguinetti, Maurizio, et al.
Publicado: (2018)

Sphingolipid/Ceramide Pathways and Autophagy in the Onset and Progression of Melanoma: Novel Therapeutic Targets and Opportunities
por: Lai, Michele, et al.
Publicado: (2019)

Unraveling the importance of molecules of natural origin in antifungal drug development through targeting ergosterol biosynthesis pathway
por: Jamzivar, Fatemehsadat, et al.
Publicado: (2019)

Fungal Cell Wall: Emerging Antifungals and Drug Resistance
por: Lima, Soraia L., et al.
Publicado: (2019)

Correction: Synthesis and Biological Properties of Fungal Glucosylceramide
por: Del Poeta, Maurizio, et al.
Publicado: (2015)

Sphingolipids in COPD
por: Chakinala, Raja Chandra, et al.
Publicado: (2019)

Involvement of Sphingolipids in Ethanol Neurotoxicity in the Developing Brain
por: Saito, Mariko, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5nud20ldb6qibghhgqh2gtsff0